IFP Advisors’s Y-mAbs Therapeutics YMAB Stock Holding History

IFP Advisors’s Portfolio YMAB Stock Details YMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-332	Closed	-$2.86K	–	5056
2025 Q3	$2.86K	Sell	332 -2	-0.6%	-$13	﹤0.01%	3546
2025 Q2	$1.51K	Buy	+334	New	+$1.5K	﹤0.01%	4024
2025 Q1	–	Hold	0	–	–	–	4010
2024 Q4	–	Hold	0	–	–	–	4054
2023 Q4	–	Sell	-103	Closed	-$561	–	3369
2023 Q3	$561	Hold	103	–	–	﹤0.01%	3090
2023 Q2	$699	Hold	103	–	–	﹤0.01%	3144
2023 Q1	$2.47K	Hold	103	–	–	﹤0.01%	2827
2022 Q4	$2K	Buy	+103	New	+$748	﹤0.01%	4241

IFP Advisors's YMAB Position: Q4 2025 in Review

IFP Advisors sold out of Y-mAbs Therapeutics (YMAB) in Q4 2025, closing a stake of 332 shares — an estimated $2.86K sold.

IFP Advisors first reported a position in YMAB in Q4 2022 and held it in 6 quarters. The position peaked at $2.86K in Q3 2025. 0 funds tracked by Wall St. Rank hold YMAB as of Q4 2025.

IFP Advisors reported no remaining Y-mAbs Therapeutics position as of Q4 2025 after selling out during the quarter.
IFP Advisors sold 332 Y-mAbs Therapeutics shares in Q4 2025, an estimated $2.86K.
IFP Advisors first reported a position in Y-mAbs Therapeutics in Q4 2022 and held it in 6 quarters.
IFP Advisors's Y-mAbs Therapeutics position peaked at $2.86K in Q3 2025.
0 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q4 2025.

Based on IFP Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.